Statistics for Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation wich is useful for preventing and/or treating multiple sclerosis exhibits an inhibitory action on T-Lymphocyte activation which is useful for preventing and/or treating multiple
Total visits
| views | |
|---|---|
| Use of spironolactone-based composition that exhibits an inhibitory action on T-lymphocyte activation wich is useful for preventing and/or treating multiple sclerosis exhibits an inhibitory action on T-Lymphocyte activation which is useful for preventing and/or treating multiple | 107 |
Total visits per month
| views | |
|---|---|
| November 2023 | 1 |
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 2 |
| May 2024 | 0 |
Top country views
| views | |
|---|---|
| Chile | 47 |
| United States | 47 |
| Kenya | 2 |
| Australia | 1 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Santiago | 47 |
| Miami | 37 |
| Alameda | 5 |
| San Francisco | 2 |
| Austin | 1 |
| Campbell | 1 |
| Nords Wharf | 1 |
| Sacramento | 1 |
| Zapopan | 1 |